Fadi A. Nabhan practices Endocrinology. He received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Fadi A. Nabhan is also a published doctor. He has 7 paper published. The most recent paper is: Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma. He is registered with Medicare.
NPI NUMBER | 1225017304 | |
NPPES Provider LastName | NABHAN | |
NPPES Provider FirstName | FADI | |
NPPES Provider ZIPCode | 432213502 | |
NPPES Provider State | OH | |
Specialty Description | Endocrinology | |
Total Claim Count | 534.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1225017304 |
Last Name Of The Provider | NABHAN |
First Name Of The Provider | FADI |
View All |
![]() |
Dr. Constantine N. Kroustos, MD
![]() |
![]() |
Dr. Samuel Cataland, MD
![]() |
![]() |
Dr. Kathleen M. Dungan, MD
![]() ![]() |
![]() |
Dr. William B. Malarkey, MD
![]() ![]() |
![]() |
Dr. Rundsarah M. Tahboub, MD
![]() |
![]() |
Dr. Shubhangi G. Shidham, MD
![]() |
![]() |
Dr. Maria J. Henwood-Finley, DO |
![]() |
Dr. Matthew D. Ringel, MD
![]() ![]() |
![]() |
Dr. Raheela A. Khawaja, MD
![]() |